Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3

被引:33
作者
Aoyama, T
Okamoto, T
Nagayama, S
Nishijo, K
Ishibe, T
Yasura, K
Nakayama, T
Nakamura, T
Toguchida, J
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto 6068507, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Surg Oncol, Kyoto 6068507, Japan
关键词
D O I
10.1074/jbc.M401273200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional regulation of cell- and stage-specific genes is a crucial process in the development of mesenchymal tissues. Here we have investigated the regulatory mechanism of the expression of the chondromodulin-I (ChM-I) gene, one of the chondrocyte-specific genes, in osteogenic cells using osteosarcoma ( OS) cells as a model. Methylation-specific sequence analyses revealed that the extent of methylation in the core-promoter region of the ChM-I gene was correlated inversely with the expression of the ChM-I gene in OS primary tumors and cell lines. 5-Aza-deoxycytidine treatment induced the expression of the ChM-I gene in ChM-I-negative OS cell lines, and the induction of expression was associated tightly with the demethylation of cytosine at -52 (C(-52)) in the middle of an Sp1/3 binding site to which the Sp3, but not Sp1, bound. The replacement of C(-52) with methyl-cytosine or thymine abrogated Sp3 binding and also the transcription activity of the genomic fragment including C(-52). The inhibition of Sp3 expression by small interfering RNA reduced the expression of the ChM-I gene in ChM-I-positive normal chondrocytes, indicating Sp3 as a physiological transcriptional activator of the ChM-I gene. These results suggest that the methylation status of the core-promoter region is one of the mechanisms to determine the cell-specific expression of the ChM-I gene through the regulation of the binding of Sp3.
引用
收藏
页码:28789 / 28797
页数:9
相关论文
共 37 条
[1]   SPECTRUM OF OSTEOBLASTIC DIFFERENTIATION IN NEW CELL-LINES DERIVED FROM SPONTANEOUS MURINE OSTEOSARCOMAS [J].
ALI, NN ;
HARRISON, MA ;
ROWE, J ;
TEICH, NM .
BONE, 1993, 14 (06) :847-858
[2]   Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta 4 subunit gene [J].
Bigger, CB ;
Melnikova, IN ;
Gardner, PD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (41) :25976-25982
[3]   Transcription factor Sp3 is essential for post-natal survival and late tooth development [J].
Bouwman, P ;
Göllner, H ;
Elsässer, HP ;
Eckhoff, G ;
Karis, A ;
Grosveld, F ;
Philipsen, S ;
Suske, G .
EMBO JOURNAL, 2000, 19 (04) :655-661
[4]   MESENCHYMAL STEM-CELLS [J].
CAPLAN, AI .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (05) :641-650
[5]  
CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990
[6]   Transcriptional mechanisms of chondrocyte differentiation [J].
de Crombrugghe, B ;
Lefebvre, V ;
Behringer, RR ;
Bi, WM ;
Murakami, S ;
Huang, WD .
MATRIX BIOLOGY, 2000, 19 (05) :389-394
[7]  
DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO
[8]  
2-V
[9]   Role for DNA methylation in the control of cell type-specific maspin expression [J].
Futscher, BW ;
Oshiro, MM ;
Wozniak, RJ ;
Holtan, N ;
Hanigan, CL ;
Duan, H ;
Domann, FE .
NATURE GENETICS, 2002, 31 (02) :175-179
[10]  
Gerstenfeld LC, 1996, LAB INVEST, V74, P895